HISAMITSU PHARMA.HISAMITSU PHARMA.HISAMITSU PHARMA.

HISAMITSU PHARMA.

No trades
See on Supercharts
Market capitalization
‪1.80 B‬EUR
‪86.19 M‬EUR
‪874.28 M‬EUR
‪34.12 M‬
Beta (1Y)
0.28

About HISAMITSU PHARMA.

Headquarters
Tosu
Founded
1847
ISIN
JP3784600003
FIGI
BBG000C5XMD5
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange HISAMITSU PHARMA. stocks are traded under the ticker HPX.
HISAMITSU PHARMA. is going to release the next earnings report on Jul 4, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for HISAMITSU PHARMA. has a max estimate of 26.0 EUR and a min estimate of 26.0 EUR.
HPX earnings for the last quarter are 0.15 EUR whereas the estimation was 0.16 EUR which accounts for −7.84% surprise. Estimated earnings for the next quarter are 0.13 EUR. See more details about HISAMITSU PHARMA. earnings.
HISAMITSU PHARMA. revenue for the last quarter amounts to ‪215.56 M‬ EUR despite the estimated figure of ‪208.19 M‬ EUR. In the next quarter revenue is expected to reach ‪424.27 M‬ EUR.
Yes, you can track HISAMITSU PHARMA. financials in yearly and quarterly reports right on TradingView.
HPX net income for the last quarter is ‪11.48 M‬ EUR, while the quarter before that showed ‪22.88 M‬ EUR of net income which accounts for −49.84% change. Track more HISAMITSU PHARMA. financial stats to get the full picture.
HISAMITSU PHARMA. dividend yield was 2.19% in 2023, and payout ratio reached 46.80%. The year before the numbers were 2.21% and 57.10% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, HPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HISAMITSU PHARMA. stock right from TradingView charts — choose your broker and connect to your account.
HPX reached its all-time high on Jun 20, 2018 with the price of 78.0 EUR, and its all-time low was 9.0 EUR and was reached on Aug 5, 2003.
See other stocks reaching their highest and lowest prices.
We've gathered analysts' opinions on HISAMITSU PHARMA. future price: according to them, HPX price has a max estimate of 26.02 EUR and a min estimate of 26.02 EUR. Read a more detailed HISAMITSU PHARMA. forecast: see what analysts think of HISAMITSU PHARMA. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HISAMITSU PHARMA. EBITDA is ‪112.67 M‬ EUR, and current EBITDA margin is 12.94%. See more stats in HISAMITSU PHARMA. financial statements.